# Phase 4 Trial to Evaluate the Efficacy and Safety of Sancuso Patch in CINV (Chemotherapy-induced Nausea and Vomiting) Associated With the Administration of MEC (Moderately Emetogenic Chemotherapy)

> **NCT01662687** · PHASE4 · UNKNOWN · sponsor: **LG Life Sciences** · enrollment: 276 (estimated)

## Conditions studied

- Chemotherapy-induced Acute or Delayed Nausea and Vomiting (CINV)

## Interventions

- **DRUG:** Sancuso patch
- **DRUG:** Kytril inj.+Kytril tab.

## Key facts

- **NCT ID:** NCT01662687
- **Lead sponsor:** LG Life Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-02
- **Primary completion:** 2012-10
- **Final completion:** 2012-11
- **Target enrollment:** 276 (ESTIMATED)
- **Last updated:** 2012-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01662687

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01662687, "Phase 4 Trial to Evaluate the Efficacy and Safety of Sancuso Patch in CINV (Chemotherapy-induced Nausea and Vomiting) Associated With the Administration of MEC (Moderately Emetogenic Chemotherapy)". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT01662687. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*